Illumina Works To Contribute Its Technology To “The Era of the Genome”

Creating a COVID-19 vaccine was a highly collaborative effort between scientists across different realms of biotechnology research. Among these contributing groups of scientists is Illumina, a company that has dedicated itself to genetic variation and biological function studies since 1998, sequencing DNA, and genotyping to learn gene expressions...